サマリー

日本脳炎ワクチンの世界市場 2022-2026 年
Technavioは日本脳炎ワクチン市場を監視しており、2022-2026年の間に5827万ドルの成長が見込まれ、予測期間中にCAGR5.98%で加速しています。当レポートでは、日本脳炎ワクチン市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、国の予防接種計画への盛り込み、日本脳炎ワクチン開発のための戦略的提携、啓発キャンペーンの増加によって牽引されています。
日本脳炎ワクチン市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの日本脳炎ワクチン市場は、以下のようにセグメント化されています。
タイプ別
- 不活性化ワクチン
- 遺伝子組換えワクチン
- 弱毒性生ワクチン
地理的状況別
- アジア
- その他の地域(ROW)
- 欧州
- 北アメリカ
本調査では、今後数年間における日本脳炎ワクチン市場の成長を牽引する主要な理由の一つとして、新規ワクチン技術を挙げています。また、BRICSの研究への強力な投資とアジアへのインバウンド旅行の増加が、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。日本脳炎ワクチン市場に関する当レポートの対象領域は以下の通りです。
- 日本脳炎ワクチン市場のサイジング
- 日本製脳炎ワクチン市場予測
- 日本製脳炎ワクチン市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Adimmune Corp.、Bharat Biotech Ltd.、Biological E. Ltd.、KM Biologics Co., Ltd.を含む日本脳炎ワクチン市場の主要ベンダー数社の詳細分析を提供します。Ltd.、Medigen Inc.、Panacea Biotec Ltd.、Sanofi、Shandong Hengye Biotechnology Co.Ltd.、Valneva SEが含まれています。また、日本脳炎ワクチン市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/japanese-encephalitis-vaccines-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Inactivated vaccines - Market size and forecast 2021-2026
o Exhibit 28: Chart on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
o 5.4 Recombinant vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Live attenuated vaccines - Market size and forecast 2021-2026
o Exhibit 36: Chart on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 Asia - Market size and forecast 2021-2026
o Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.4 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 50: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.5 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.6 North America - Market size and forecast 2021-2026
o Exhibit 58: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.7 China - Market size and forecast 2021-2026
o Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.8 India - Market size and forecast 2021-2026
o Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.9 Japan - Market size and forecast 2021-2026
o Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.10 Republic of Korea - Market size and forecast 2021-2026
o Exhibit 74: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
o 7.11 Australia - Market size and forecast 2021-2026
o Exhibit 78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Australia - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Adimmune Corp.
o Exhibit 89: Adimmune Corp. - Overview
o Exhibit 90: Adimmune Corp. - Business segments
o Exhibit 91: Adimmune Corp. - Key news
o Exhibit 92: Adimmune Corp. - Key offerings
o Exhibit 93: Adimmune Corp. - Segment focus
o 10.4 Bharat Biotech Ltd.
o Exhibit 94: Bharat Biotech Ltd. - Overview
o Exhibit 95: Bharat Biotech Ltd. - Product / Service
o Exhibit 96: Bharat Biotech Ltd. - Key news
o Exhibit 97: Bharat Biotech Ltd. - Key offerings
o 10.5 Biological E. Ltd.
o Exhibit 98: Biological E. Ltd. - Overview
o Exhibit 99: Biological E. Ltd. - Product / Service
o Exhibit 100: Biological E. Ltd. - Key news
o Exhibit 101: Biological E. Ltd. - Key offerings
o 10.6 KM Biologics Co. Ltd.
o Exhibit 102: KM Biologics Co. Ltd. - Overview
o Exhibit 103: KM Biologics Co. Ltd. - Product / Service
o Exhibit 104: KM Biologics Co. Ltd. - Key offerings
o 10.7 Medigen Inc.
o Exhibit 105: Medigen Inc. - Overview
o Exhibit 106: Medigen Inc. - Product / Service
o Exhibit 107: Medigen Inc. - Key offerings
o 10.8 Panacea Biotec Ltd.
o Exhibit 108: Panacea Biotec Ltd. - Overview
o Exhibit 109: Panacea Biotec Ltd. - Product / Service
o Exhibit 110: Panacea Biotec Ltd. - Key offerings
o 10.9 Sanofi
o Exhibit 111: Sanofi - Overview
o Exhibit 112: Sanofi - Business segments
o Exhibit 113: Sanofi - Key news
o Exhibit 114: Sanofi - Key offerings
o Exhibit 115: Sanofi - Segment focus
o 10.10 Shandong Hengye Biotechnology Co. Ltd.
o Exhibit 116: Shandong Hengye Biotechnology Co. Ltd. - Overview
o Exhibit 117: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
o Exhibit 118: Shandong Hengye Biotechnology Co. Ltd. - Key offerings
o 10.11 Valneva SE
o Exhibit 119: Valneva SE - Overview
o Exhibit 120: Valneva SE - Business segments
o Exhibit 121: Valneva SE - Key offerings
o Exhibit 122: Valneva SE - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Adimmune Corp. - Overview
Exhibits90: Adimmune Corp. - Business segments
Exhibits91: Adimmune Corp. - Key news
Exhibits92: Adimmune Corp. - Key offerings
Exhibits93: Adimmune Corp. - Segment focus
Exhibits94: Bharat Biotech Ltd. - Overview
Exhibits95: Bharat Biotech Ltd. - Product / Service
Exhibits96: Bharat Biotech Ltd. - Key news
Exhibits97: Bharat Biotech Ltd. - Key offerings
Exhibits98: Biological E. Ltd. - Overview
Exhibits99: Biological E. Ltd. - Product / Service
Exhibits100: Biological E. Ltd. - Key news
Exhibits101: Biological E. Ltd. - Key offerings
Exhibits102: KM Biologics Co. Ltd. - Overview
Exhibits103: KM Biologics Co. Ltd. - Product / Service
Exhibits104: KM Biologics Co. Ltd. - Key offerings
Exhibits105: Medigen Inc. - Overview
Exhibits106: Medigen Inc. - Product / Service
Exhibits107: Medigen Inc. - Key offerings
Exhibits108: Panacea Biotec Ltd. - Overview
Exhibits109: Panacea Biotec Ltd. - Product / Service
Exhibits110: Panacea Biotec Ltd. - Key offerings
Exhibits111: Sanofi - Overview
Exhibits112: Sanofi - Business segments
Exhibits113: Sanofi - Key news
Exhibits114: Sanofi - Key offerings
Exhibits115: Sanofi - Segment focus
Exhibits116: Shandong Hengye Biotechnology Co. Ltd. - Overview
Exhibits117: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
Exhibits118: Shandong Hengye Biotechnology Co. Ltd. - Key offerings
Exhibits119: Valneva SE - Overview
Exhibits120: Valneva SE - Business segments
Exhibits121: Valneva SE - Key offerings
Exhibits122: Valneva SE - Segment focus
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations